As of 2026-01-24, the Relative Valuation of Bioatla Inc (BCAB) is (9.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.35 USD, the upside of Bioatla Inc based on Relative Valuation is -2669.4%.
The range of the Relative Valuation is (7.30) - (9.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 19.1x | 17.3x |
| Forward P/E multiples | 14.0x - 21.6x | 17.5x |
| Fair Price | (7.30) - (9.98) | (9.07) |
| Upside | -2167.3% - -2926.3% | -2669.4% |
| Date | P/E |
| 2026-01-20 | -0.61 |
| 2026-01-16 | -0.62 |
| 2026-01-15 | -0.61 |
| 2026-01-14 | -0.65 |
| 2026-01-13 | -0.59 |
| 2026-01-12 | -0.60 |
| 2026-01-09 | -0.69 |
| 2026-01-08 | -0.77 |
| 2026-01-07 | -0.81 |
| 2026-01-06 | -0.83 |
| 2026-01-05 | -0.82 |
| 2026-01-02 | -1.02 |
| 2025-12-31 | -1.09 |
| 2025-12-30 | -1.37 |
| 2025-12-29 | -1.50 |
| 2025-12-26 | -1.60 |
| 2025-12-24 | -1.39 |
| 2025-12-23 | -1.28 |
| 2025-12-22 | -1.53 |
| 2025-12-19 | -1.44 |
| 2025-12-18 | -1.52 |
| 2025-12-17 | -1.50 |
| 2025-12-16 | -1.46 |
| 2025-12-15 | -1.48 |
| 2025-12-12 | -1.58 |
| 2025-12-11 | -1.50 |
| 2025-12-10 | -1.48 |
| 2025-12-09 | -1.54 |
| 2025-12-08 | -1.55 |
| 2025-12-05 | -1.58 |
| 2025-12-04 | -1.63 |
| 2025-12-03 | -1.58 |
| 2025-12-02 | -1.49 |
| 2025-12-01 | -1.52 |
| 2025-11-28 | -1.73 |
| 2025-11-26 | -1.63 |
| 2025-11-25 | -1.58 |
| 2025-11-24 | -1.64 |
| 2025-11-21 | -1.67 |
| 2025-11-20 | -2.22 |
| 2025-11-19 | -2.22 |
| 2025-11-18 | -2.34 |
| 2025-11-17 | -1.96 |
| 2025-11-14 | -1.51 |
| 2025-11-13 | -1.26 |
| 2025-11-12 | -1.32 |
| 2025-11-11 | -1.31 |
| 2025-11-10 | -1.22 |
| 2025-11-07 | -1.32 |
| 2025-11-06 | -1.23 |